4.7 Article

A Histoplasma capsulatum Lipid Metabolic Map Identifies Antifungal Targets

Journal

MBIO
Volume 12, Issue 6, Pages -

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/mBio.02972-21

Keywords

Histoplasma capsulatum; drug targets; lipid metabolism; lipidomics; metabolic map; proteomics

Categories

Funding

  1. NIH [R21 AI124797]
  2. Laboratory-Directed Research and Development project from Pacific Northwest National Laboratory (PNNL)
  3. NIEHS [P42 ES027704]

Ask authors/readers for more resources

This study built a comprehensive map of the Histoplasma capsulatum lipid metabolic pathway by incorporating proteomic and lipidomic analyses. The map identified fatty acid desaturation and sphingolipid biosynthesis pathways as targets for drug development. Experimental results showed inhibitors of these pathways effectively inhibited H. capsulatum growth.
Lipids play a fundamental role in fungal cell biology, being essential cell membrane components and major targets of antifungal drugs. A deeper knowledge of lipid metabolism is key for developing new drugs and a better understanding of fungal pathogenesis. Here, we built a comprehensive map of the Histoplasma capsulatum lipid metabolic pathway by incorporating proteomic and lipidomic analyses. We performed genetic complementation and overexpression of H. capsulatum genes in Saccharomyces cerevisiae to validate reactions identified in the map and to determine enzymes respon-sible for catalyzing orphan reactions. The map led to the identification of both the fatty acid desaturation and the sphingolipid biosynthesis pathways as targets for drug devel-opment. We found that the sphingolipid biosynthesis inhibitor myriocin, the fatty acid desaturase inhibitor thiocarlide, and the fatty acid analog 10-thiastearic acid inhibit H. capsulatum growth in nanomolar to low-micromolar concentrations. These compounds also reduced the intracellular infection in an alveolar macrophage cell line. Overall, this lipid metabolic map revealed pathways that can be targeted for drug development. IMPORTANCE It is estimated that 150 people die per hour due to the insufficient therapeutic treatments to combat fungal infections. A major hurdle to developing antifungal therapies is the scarce knowledge on the fungal metabolic pathways and mechanisms of virulence. In this context, fungal lipid metabolism is an excellent can-didate for developing drugs due to its essential roles in cellular scaffolds, energy storage, and signaling transductors. Here, we provide a detailed map of Histoplasma capsulatum lipid metabolism. The map revealed points of this fungus lipid metabo-lism that can be targeted for developing antifungal drugs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available